AMPA6750
HIP1R Monoclonal Antibody (1E1), Invitrogen™
Manufacturer: Thermo Scientific
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | AMPA6750-Each-of-1 | In Stock | ₹ 47,837.50 |
AMPA6750 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 47,837.50
GST (18%): ₹ 8,610.75
Total Price: ₹ 56,448.25
Antigen
HIP1R
Classification
Monoclonal
Concentration
7.7 mg/mL
Formulation
ascites with 0.1% sodium azide
Gene Accession No.
O75146, Q9JKY5
Gene Symbols
HIP1R
Immunogen
Human HIP1r-TALIN Homology Region (57 kDa).
Regulatory Status
RUO
Gene ID (Entrez)
29816, 81917, 9026
Content And Storage
-20° C, Avoid Freeze/Thaw Cycles
Form
Liquid
Applications
Immunohistochemistry (Paraffin), Immunoprecipitation, Western Blot
Clone
1E1
Conjugate
Unconjugated
Gene
HIP1R
Gene Alias
AA410023; HIP12; HIP-12; Hip1r; HIP1-related protein; HIP3; huntingtin interacting protein 1 related; huntingtin interacting protein 12; Huntingtin-interacting protein 12; huntingtin-interacting protein 1-related protein; ILWEQ; KIAA0655; mKIAA0655
Host Species
Mouse
Quantity
100 μL
Primary or Secondary
Primary
Target Species
Bacteria, Human, Mouse, Rat
Product Type
Antibody
Isotype
IgG1 κ
Related Products
Description
- Suggested positive control: HeLa whole cell lysate and rat brain homogenate, Hela whole cell lysate, antigen standard for IFT57 (transient overexpression lysate), rat brain protein
- Huntingtin disease, a neurodegenerate disease, is caused by the expansion of a polymorphic glutamine tract in huntingtin
- The Huntingtin Interacting Protein 1 (HIP-1) is a reportedly proapoptotic, cargo-specific adaptor protein that may be involved in the pathogenesis of Huntingtin disease
- As well as playing a role in Huntingtin disease, it is likely to be involved in the recruitment of clathrin coats to lipid membranes and it may also factor in tumorigenesis by allowing the survival of precancerous and cancerous cells
- Since HIP-1 expression is significantly associated with prostate and colon cancer metastasis, HIP-1 can serve as a putative prognostic factor for prostate and colon cancers.